Bank of America Corp
Change company Symbol lookup
Select an option...
BAC Bank of America Corp
KVHI KVH Industries Inc
BHC Bausch Health Companies Inc
ANPC AnPac Bio-Medical Science Co Ltd
TREX Trex Company Inc
VIVO Meridian Bioscience Inc
WASH Washington Trust Bancorp Inc
AWF AllianceBernstein Global High Income Fund Inc.
AVK Advent Convertible & Income Fund
AVK Advent Convertible & Income Fund
Go

Financials : Banks | Large Cap Value
Company profile

Bank of America Corporation is a bank holding company and a financial holding company. The Company is a financial institution, serving individual consumers and others with a range of banking, investing, asset management and other financial and risk management products and services. The Company, through its banking and various non-bank subsidiaries, throughout the United States and in international markets, provides a range of banking and non-bank financial services and products through four business segments: Consumer Banking, which comprises Deposits and Consumer Lending; Global Wealth & Investment Management, which consists of two primary businesses: Merrill Lynch Global Wealth Management and U.S. Trust, Bank of America Private Wealth Management; Global Banking, which provides a range of lending-related products and services; Global Markets, which offers sales and trading services, and All Other, which consists of equity investments, residual expense allocations and other.

Premarket

Last Trade
Delayed
$24.52
-0.38 (-1.53%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$24.90
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
251,379

10-day average volume:
60,060,344
251,379

Abiomed gets emergency authorization to use heart pump in COVID-19 patients

7:42 am ET June 1, 2020 (MarketWatch)
Print

Shares of Abiomed Inc. (ABMD) were down 0.04% in premarket trading on Monday after the company said it had received an emergency use authorization from the Food and Drug Administration for its Impella RP heart pump to be used in certain COVID-19 patients, including those with heart failure. The medical device had received FDA approval in 2017 to be marketed in the treatment of right ventricular failure. "Acute pulmonary embolism is clearly being recognized as a life-threatening manifestation of COVID-19," Dr. Amir Kaki, director of mechanical circulatory support at Ascension St. John Hospital in Detroit, said in the Abiomed release. Abiomed's stock is up 31.2% year-to-date. The S&P 500 has declined 5.7% since the start of the year.

-Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

June 01, 2020 07:42 ET (11:42 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.